Literature DB >> 1319665

Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.

B Ecarot1, F H Glorieux, M Desbarats, R Travers, L Labelle.   

Abstract

The hypophosphatemic (Hyp) mouse is the murine homolog for human hypophosphatemic vitamin D-resistant rickets. We previously reported that bone cells isolated from normal and Hyp mice produced abnormal bone when transplanted intramuscularly into mutant mice. To assess the role of hypophosphatemia on bone formation in transplants, normal and Hyp mouse periostea were pair transplanted into control or phosphate (P)-supplemented Hyp mice and into control or P-deprived normal mice. The bone nodules formed in transplants after 2 weeks were characterized by measuring the thickness of the surrounding osteoid seams and the relative osteoid volume. P restriction in normal recipient mice impaired bone formation by transplanted normal cells and aggravated the defective bone formation by Hyp cells. The osteoid thickness and volume remained significantly higher in Hyp transplants than in normal cotransplants, however. P supplementation of Hyp recipient mice normalized bone formation by transplanted normal cells but not by Hyp cells. However, a marked decrease in osteoid thickness and volume was observed in Hyp transplants down to values observed in normal recipient mice. These results indicate that hypophosphatemia is not the only cause of abnormal bone formation in the Hyp mouse but that an osteoblast dysfunction contributes to the bone disease. These observations further support the concept that the osteoblast may be an important target for the Hyp mutation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319665     DOI: 10.1002/jbmr.5650070508

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

1.  Cellular ATP synthesis mediated by type III sodium-dependent phosphate transporter Pit-1 is critical to chondrogenesis.

Authors:  Atsushi Sugita; Shinji Kawai; Tetsuyuki Hayashibara; Atsuo Amano; Takashi Ooshima; Toshimi Michigami; Hideki Yoshikawa; Toshiyuki Yoneda
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).

Authors:  Peter S N Rowe; Ian R Garrett; Patricia M Schwarz; David L Carnes; Eileen M Lafer; Gregory R Mundy; Gloria E Gutierrez
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

3.  Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

Authors:  Peter S N Rowe; Naoko Matsumoto; Oak D Jo; Remi N J Shih; Jeannine Oconnor; Martine P Roudier; Steve Bain; Shiguang Liu; Jody Harrison; Norimoto Yanagawa
Journal:  Bone       Date:  2006-06-09       Impact factor: 4.398

4.  Phosphate transport in osteoblasts from normal and X-linked hypophosphatemic mice.

Authors:  L Rifas; L L Dawson; L R Halstead; M Roberts; L V Avioli
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

Review 5.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

6.  Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.

Authors:  Baozhi Yuan; Masanori Takaiwa; Thomas L Clemens; Jian Q Feng; Rajiv Kumar; Peter S Rowe; Yixia Xie; Marc K Drezner
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Chronic inhibition of ERK1/2 signaling improves disordered bone and mineral metabolism in hypophosphatemic (Hyp) mice.

Authors:  Martin Y H Zhang; Daniel Ranch; Renata C Pereira; Harvey J Armbrecht; Anthony A Portale; Farzana Perwad
Journal:  Endocrinology       Date:  2012-02-14       Impact factor: 4.736

8.  MEPE has the properties of an osteoblastic phosphatonin and minhibin.

Authors:  P S N Rowe; Y Kumagai; G Gutierrez; I R Garrett; R Blacher; D Rosen; J Cundy; S Navvab; D Chen; M K Drezner; L D Quarles; G R Mundy
Journal:  Bone       Date:  2004-02       Impact factor: 4.398

9.  Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.

Authors:  Teruyo Nakatani; Mutsuko Ohnishi; M Shawkat Razzaque
Journal:  FASEB J       Date:  2009-07-07       Impact factor: 5.191

10.  Altered osteoblast gluconeogenesis in X-linked hypophosphatemic mice is associated with a depressed intracellular pH.

Authors:  L Rifas; A Gupta; K A Hruska; L V Avioli
Journal:  Calcif Tissue Int       Date:  1995-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.